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Abstract Building a mathematical model of population
dynamics of pathogens within their host involves consid-
erations of factors similar to those in ecology, as pathogens
can prey on cells in the host. But within the multicellular
host, attacked cell types are integrated with other cellular
systems, which in turn intervene in the infection. For
example, immune responses attempt to sense and then
eliminate or contain pathogens, and homeostatic mecha-
nisms try to compensate for cell loss. This review focuses
on modeling applied to malarias, diseases caused by single-
cell eukaryote parasites that infect red blood cells, with
special concern given to vivax malaria, a disease often
thought to be benign (if sometimes incapacitating) because
the parasite only attacks a small proportion of red blood
cells, the very youngest ones. However, I will use
mathematical modeling to argue that depletion of this pool
of red blood cells can be disastrous to the host if growth of
the parasite is not vigorously check by host immune
responses. Also, modeling can elucidate aspects of new
field observations that indicate that vivax malaria is more
dangerous than previously thought.
Keywords Population dynamics .Malaria . Age structured
population . Biological delay models
Introduction
Population biology is concerned with the dynamics of a
population of organisms and influences on those dynam-
ics. For example, consider a herd of zebras on a plain.
Lions and hyenas prey on the zebras. If there is a drought,
fewer zebras may survive, thus fewer lions and hyenas
survive. Lions and hyenas compete against each other,
and parasites infect both zebras and predators. A less
nutritious grass may invade the plain, etc. From a
biophysical standpoint, interactions among the species
facilitate the exchange of energy along with nutrients
necessary to use that energy. The plain is a substrate on
which natural selection acts on the component species and
thus shapes their genomes. Mathematical modeling of an
ecosystem lets us investigate “what if” situations: given a
proposed interaction or process in the ecosystem, what is
the logical outcome of the presence of that interaction or
process upon the dynamics of the populations in that
system? Will these outcomes be robust against perturba-
tions on the system? To quote John Maynard Smith
(Maynard Smith 1968), modeling (1) “provides a rapid
way of discovering the kind of effect various features—for
examples, predation, parasitism, territorial behavior, a
long or short period of immaturity—may have on the
behavior of a population” and (2) “suggests what needs to
be measured before the behavior of any particular species
can be understood.”
A group of pathogenic agents in a multicellular host also
forms a population. The pathogen is a predator if it attacks
a cell type. But multicellular hosts are usually proactive
against an invader, mounting immune responses to kill or
limit the pathogen and starting processes to repair the tissue
damage. From a modeler’s perspective, perhaps the
ecosystem is a morass: we may not know all the
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components of the host’s response, and of those we do
know, we may not know which are most important. Host
responses may be self-amplifying, self-regulating, and
possibly self-harming. They may differ greatly among
individuals of the same species due to genetic background
or contingency of environmental exposure. The pathogen
might have mechanisms to evade or interfere with host
responses. But again, we can use mathematical modeling to
answer “what-if” questions, and this in turn can guide
researchers in the laboratory or clinic. There are two levels
of population dynamics in a host-pathogen system: (1)
those of individual cells or virions of the invader as well as
host cells and responses, and (2) those of both host
population and disease incidence, the subject of epidemi-
ology. In this review, I discuss the application of mathe-
matical modeling to a type of human malaria, with the
focus on the within-host dynamics of the pathogen. I will
also discuss the significance of the results from both public
health and evolutionary standpoints.
A conundrum of malaria biology
Malarias are diseases of red blood cells (RBCs) in
vertebrates caused by 100+ species of single-cell eukar-
yotes of the genus Plasmodium, order Haemosporida of
the class Apicomplexa. Birds, reptiles, and mammals are
targeted (Garnham 1966; Perkins and Austin 2009).
Apicomplexans have a set of specialized organelles,
together called the apical complex, that enables them to
penetrate the cells of their hosts. All known Apicomplex-
ans are intracellular parasites, and some are human disease
agents (Cryptosporidium parvum, Toxoplasma gondii) or
serious livestock pathogens (Babesia spp., Theileria spp.).
At least five Plasmodium spp. infect humans regularly,
causing disease characterized by repeating bouts of severe
fever and anemia [see Cox-Singh and Singh (2008) for
commentary]. Part of the life cycle of these species is
spent in mosquitoes of genus Anopheles. The mosquitoes
serve as vectors that spread the disease from human to
human by picking up the gametocytes, the sexual forms of
the parasite that mate within the mosquito gut. Mosquitoes
transmit to humans the haploid descendants of the mated
forms, the sporozoites, which then enter liver cells. The
form of parasite that infects RBCs is the merozoites, which
are released initially from the liver as the descendants of
sporozoites but then later by the bursting of infected
RBCs. [Baer et al. (2007) is an illustrative study of the
initial merozoite release.] After a merozoite enters an
RBC, its nucleus undergoes rounds of division by
schizogony. The infection is sustained among the host’s
RBCs in this manner, but some asexual forms become
gametocytes in a process that is not well understood. The
disease pathology is due to the asexual forms that cannot
be transmitted to mosquitoes, although blood transfusion
can spread them.
Two species, Plasmodium falciparum and Plasmodium
vivax, cause the bulk of the public health burden of the
malarias. [For review, see White and Breman (2008) and
Miller et al. (2002).] P. vivax attacks mainly reticulocytes,
which are RBCs that have aged 36 h or less after
differentiation from erythroblasts and that still retain traces
of a nucleus. This parasite infects ≈108 people per year in
both temperate and tropical areas. Infection is temporarily
incapacitating, but as I discuss below, its true public health
burden is only now becoming apparent. P. falciparum can
infect RBCs of any age. This species infects ≈5×108 people
each year and causes >106 deaths per year, mostly in
tropical regions and especially in sub-Saharan Africa.
Severe anemia and organ complications, especially in the
brain, cause death or long term disability. Figure 1 shows a
human RBC parasitized with this species.
In 2003, Ellis McKenzie of the National Institutes of
Health, Bethesda, approached me with a conundrum: It was
assumed that P. vivax caused less severe disease than
P. falciparum because a mere 1.25% of RBCs are
reticulocytes (Krogstad 1995). Yet data from neurosyphilis
patients who were infected with P. vivax showed that this
parasite has a rather large growth rate early in infection,
with parasites from a single infected RBC infecting up to
15 other RBCs (McKenzie et al. 2002). (Before penicillin
Fig. 1 Lurking among human RBCs (stained red) is one infested with
the schizont form of Plasmodium falciparum. Violet stains show DNA
in parasitic nuclei (arrow), which were produced by schizogony after
a single-nucleus form of the parasite invaded this erythrocyte. Image
credit: 3D confocal microscopy and image processing performed by
Drs. Fuyuki Tokumasu and James Dvorak (deceased), Laboratory of
Malaria and Vector Research, National Institute of Allergy and
Infectious Diseases, National Institutes of Health. Used by permission
of Dr. Tokumasu
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came into use, the induction of antibacterial fever by
malaria was the standard of treatment for neurosyphilis.)
This was similar to the initial growth rate of parasitemia
seen in P. falciparum infections in neurosyphilis patients
(Collins and Jeffery 1999) and other patient groups (White
1997). Could P. vivax cause severe anemia by depleting the
reticulocyte population, thus choking off replacements for
aging RBCs removed by the spleen? If so, what makes P.
vivax supposedly less dangerous than P. falciparum? We set
about modeling the dynamics of the parasite population in
an hypothetical patient to address this question. This review
describes the results of our efforts.
Incidentally, there are many fine theoretical studies of
the within-host population dynamics of malaria parasites
that attempt to address several aspects of malaria infection.
For a selection, see Gravenor et al. (1995), Hoshen et al.
(2000), Gravenor et al. (2002), Rouzine and McKenzie
(2003), Haydon et al. (2003), Maire et al. (2006), Chiyaka
et al. (2009), and Thibodeaux (2010).
Starting with Malthus
We first considered the following question: what would
happen if parasitemia grew to the maximum level con-
strained only by availability of RBCs, with no immune
response from the host against the parasite? This situation
resembles Malthusian growth of the within-host parasite
population, although Mathus was primarily concerned with
the effects of human population growth on economies. But
the basic idea is that a population grows unchecked until
limited by availability of resources, and the growth can lead
to catastrophe for the population if the host dies due to
anemia. (However, if a mosquito has picked up some of the
gametocytes, the catastrophe is not for the Plasmodium
species itself. The within-host population is sacrificed.) The
1798 essay of Malthus had a great impact on biologists in
the 19th century and is considered one of the founding
works in population biology (Malthus 2003). In some ways,
the models that I describe are akin to the logistics equation
introduced byMalthus’s younger contemporary P.F. Verhulst
to account for population growth limited by a resource
(Hoppensteadt 1982). Before introducing the models, I
must introduce two important concepts.
Concept I: basic reproduction rate
The lifetime τμ of a free merozoite is ≈10 min (Johnson et
al. 1980), much shorter than the development time of the
parasite within RBCs (≈2 days for both P. vivax and P.
falciparum). The difference between these time scales
allows us to derive, by statistical arguments, the average
number of descendants an infected RBC has after one
development cycle, R, early in the infection before an
immune response can respond (or if there is no immune
response). Assuming that all vulnerable RBCs are equally
likely to be invaded, we introduce a merozoite-RBC
binding affinity z, so that the rate of infection of RBCs
per unit volume of blood, Infr, is
Infr ¼ zVm ð1Þ
where μ is the density of merozoites in the blood, and V is
the density of vulnerable RBCs (reticulocytes for P. vivax,
all RBCs for P. falciparum). Making an additional
assumption that early in the infection V changes slowly
during one cycle of the within-RBC parasite, we obtain
R ¼ ptmzV
1þ tmzV ð2Þ
Here p is the average number of merozoites released
from an infected RBC. [The details of the derivation are
given in McQueen and McKenzie (2004)]. Direct photo-
graphic evidence of bursting infected RBCs suggests that
p≈16 (Glushakova et al. 2005). As already mention in the
section “A conundrum of malaria biology” above, R for
both species at the beginning of infection is ≈15. Thus, the
asexual forms of both species are very effective at
propagating themselves before host immune reactions can
intervene, with a characteristic time to invade an RBC zV≈
24 s. I call the initial value of R the basic reproductive rate,
R0. Given V, τμ, and p, knowing R0 determines z. As
infection progresses, R declines from R0 because (1) the
vulnerable RBC population is depleted and (2) the host
mounts an immune response against the parasite.
Concept II: populations consist of aging individuals
To develop a reasonable mathematical model, one has to
treat the various constituents of the pathogen-host system
(the erythocytes, the parasite, etc.) as populations of aging
individuals: that is, on a population average, individuals
spend D amount of time in a given stage of development
with some standard deviation σ. If simple rate equations
were used to model the population levels of the constitu-
ents, then population level changes would be like that of
radioactive nuclei decaying at random. Yet the development
time of an individual parasite within an RBC is 48 h for the
two species, with maybe a few hours of variation.
Reticulocytes last only 36 h, plus or minus a few hours.
Individuals in such populations are not like radioactive
nuclei that randomly “pop” with probability per unit time of
D−1. To account realistically for aging, we used the
technique of compartment ordinary differential equations
in which a stage of development of an organism (with
duration D) is described as a set of N substages with
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duration DN−1 that decay into one another. Letting Pn be
the population in substage n (and ignoring interactions










ðPn1  PnÞ; 1 < n  N :
ð3Þ
It can be shown that the standard deviation about D for




I stress that D, σ, and the total population ΣPn are the
tangible quantities connected to measurement, not N. The N
substage populations are just a fictional construct. This
technique was developed in the 1960s for population
modeling, with Lloyd adapting it to epidemiology and
within-host pathogen population dynamics (Lloyd 2001a, b).
[See also supplementary material in McQueen and McKenzie
(2004).] We wrote a set of modular code libraries in Java
(now in C++) that allowed for rapid modification of the
numerical model as needed. It was found that a fourth-order
Runge-Kutta method with adaptive time stepping (Cash and
Karp 1990) worked very well to solve the ordinary differential
equation system arising from the application of Eqs. 3 and 4,
even though such systems might contain hundreds of
dependent variables.
The erythocyte-limited model
This model was first described in McQueen and McKenzie
(2004); it can thought as two developmental chains, one for
RBCs and the other for the parasite. The stages of each
chain are indicated in Fig. 2. For each such stage, a system
of differential equations similar to Eq. 3 describes the
population changes; the corresponding values of D and σ
are also shown in Fig. 2. The two chains interact through
the binding of merozoites to the vulnerable RBCs, as
described in Eq. 1. For convenience of the reader, the full
system of differential equations that describe this model is
given in the Electronic supplementary material (ESM).
The simulation is started with a small number of
merozoites to mimic the primary release of merozoites
from the liver. The normal basal production rate for human
RBCs is about 1,736 μl−1 h−1; we considered models in
which this rate could be amplified to compensate for the
RBC loss due to infection. We also considered models with
dyserythropoiesis, a decline in the rate of production due to
factors of the parasite. [For a review of observed effects of
malaria upon erythropoiesis, see Wickramasinghe and
Abdalla (2000).] For some sets of simulations, we varied
the σ for the erythrocytic stage of the parasite to test the
effects of changes in this model parameter upon the results.
This will be discussed more in the section “Sensitivity to
the standard deviation of the life cycletime of the intra-
erythrocyte parasite.”
Plasmodium vivax is an insidious pathogen
The erythrocyte-limited model of parasite dynamics predicts
that even for a basic reproduction rateR0≤2, P. vivax infection
would eventually deplete the reticulocyte pool enough to kill
the patient: there would not be enough replacements for aged
RBCs removed by the spleen (McQueen and McKenzie
2004). Figure 3 shows some typical simulation results. [The
results in the figure are slightly different from those
presented in McQueen and McKenzie (2004) because (1) σ
of the infected RBC stage is 2.4 h instead of 4.8 h as in that
paper, and (2) the level of lethal anemia was set lower than in
that paper.] One effect apparent in Fig. 3 is that a
compensatory response of RBC production would make
matters worse for the host with P. vivax infection by
lowering the value of R0 at which death via severe anemia
could occur, as well as increasing the overall parasitemia.
Conversely, dyserythropoiesis would tend to lower the
number of parasites produced in lethal infections. These
latter effects would also occur in the resource-limited model
of P. falciparum infection, but then there is less effect on the
survival of the host (see Fig. S1 in the ESM).
Fig. 2 The development chains assumed for normal and infected
RBCs. Plasmodium malariae attacks human senescent RBCs; see the
section “Plasmodium vivax is an insidious pathogen” concerning this
parasite
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Since R0≈15 in actual infections, even in patients who
survive the disease, human immune constraints on the
growth of P. vivax must be very tight indeed! Even though
the erythropoietic function affects some of the details of the
erythrocyte-limited model infection outcome, infection with
P. vivax in this model would be lethal even if R0 were just
above 1 regardless of the erythropoietic function.
The importance of the age-structured nature of the attack
of P. vivax becomes apparent when examining Fig. 4, which
shows results for simulations using parameters for the
pathogen Plasmodium malariae, an attacker of senescent
human RBCs. [The duration of the infected RBC stage for
this pathogen is 72 h instead of 48 h. See McKenzie et al.
(2001) for a review of knowledge about this parasite.] No
simulated P. malariae infection ended in host death unless
there was dyserythropoiesis, even though P. malariae
attacks a slightly larger subset of RBCs in this model.
Since no other stage of RBC development depends on the
senescent cells, depletion of this population would not
cause severe anemia unless a secondary effect disrupted the
production of RBCs or killed uninfected RBCs.
If both P. vivax and P. falciparum infect the host in an
erythrocyte-limited model, the results depend on which
infects first, and their respective values of R0. Basically, we
found that the species with the largest value of R0
dominates. See McQueen and McKenzie (2006) for more
detailed discussion.
Fig. 4 Panels a and b are the same as in Fig. 3, except that the model
pathogen is P. malariae; see the section “Plasmodium vivax is an
insidious pathogen” for details. Curves are the same erythropoietic
responses as in Fig. 3. Note for a: only simulation with dyserythro-
poiesis ended with death of the host
Fig. 3 a Time of death for simulated P. vivax infection, TD, assuming
no immune constraints, as a function of basic reproduction rate R0. b
Corresponding total number of RBCs parasitized during the infection,
IBCINT. The basal results are for an erythocyte production rate at its
basal value; comp results are for a production rate up to five times the
basal value to compensate for blood loss due to infection; and dys
results assume dyserythropoiesis: the production rate reduced by an
amount equal to twice the rate of depletion of RBCs by infection.
Infections were simulated for 5 years unless the RBC count dropped
below 60% of the basal count, at which point the host was assumed to
have died from anemia and the simulation was terminated. Each curve
is the result of simulations at 1,000 random values for R0 chosen
uniformly on the interval [1.01, 15.0]. Note: Log-log scale for both
axes; horizontal axis is log (R0−1) in order to emphasize the
differences between the curves
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Adding host immunity
In real malaria infections, hosts mount aggressive immune
responses, both innate and adaptive. For example, the
report of Karunaweera et al. (1992) illustrates the quick
production (and then decay) of cytokines associated with
innate responses in patients infected by P. vivax. [Some
good reviews of immune responses to malaria are
Engwerda and Good (2005), Karunaweera et al. (2003),
and Plebanski and Hill (2000).] To address how the
presence of immune responses might affect the virulence
of Plasmodium spp., we added additional components to
the model to incorporate two types of immune reactions: (1)
a fast acting, fast decaying response to mimic the intense
innate reactions seen in malarias, and (2) a slowly
activating, slowly decaying response to mimic an antibody
response. Since some of the innate immune reaction is
believed to be triggered by the bursting of the schizonts, the
model innate response is triggered when the level of late-
stage-infected RBCs is above a threshold (that varies from
simulation to simulation). Then a factor is produced that
attacks some subset of the parasite; the rate of removal of
parasites, C, would be
C ¼ xInnAttInnP ð5Þ
Here, AttInn is the attacker level in the blood for the
model innate reaction, ξInn is the binding affinity of the
attacker to the targeted parasites, and P is the subset of
parasite population that is attacked. (For example, it could be
only infected RBCs that are trophozoites. In another
simulation it might be only schizonts.) In a sense, it is the
product ξInnAttInn that is the tangible quantity, as it is a rate of
removal. Themodel antibody response is similar, except that a
delay is incorporated before the level of the attacker factor
grows; a formalism similar to that of Eq. 3 above enforces the
delay. The dynamics of both types of immune responses are
modeled with a system of differential equations; for details
see McQueen and McKenzie (2008). Also, the immune
components of the model are expounded in the ESM.
The targets, trigger levels, and binding affinities of both
types of responses were varied so that simulations were
performed for thousands of points in the parameter space of
the models. (In addition, we consider several values of σ for
the infected erythrocyte stage; see the section “Sensitivity
to the standard deviation of the life cycletime of the
intraerythrocyte parasite” below.) The main conclusion is
that given an immune response with the same capacity to
detect and clear parasites, P. vivax infection would be just
as severe in terms of risk of lethal outcome as P.
falciparum. This can be seen in Fig. 5, which shows the
results of simulations with basic reproduction rate R0=15
but with immune responses present. In most of the phase
space of the model immune parameters, the immune
responses protect the host from death by severe anemia. A
compensatory increase in the rate of erythropoiesis to blood
cell loss due to infection tends to boost overall parasitemia,
especially for P. vivax, although the fraction of phase space
in which the host dies is about same as for the case when
the erythropoiesis is fixed at the basal rate. On the other
hand, dyserythropoiesis tends to reduce on average the
burden of parasitemia to which the host can mount an
immune response, but increases the fraction of phase space
that is lethal to the host, especially for P. vivax. One
Fig. 5 a Fraction of points in the parameter space of the model with
immune responses in which simulated infection ended with death of
host as a function of the type of erythropoietic response. The fraction
is of 9,520 simulations: 2,380 combinations of immune response
parameters, each with four values of σ for the duration of the infected
RBC stage. b The number of parasites produced during infection,
IBCINT, averaged over all points in parameter space for those four
types of erythropoietic responses. c Symbols used for the two
Plasmodium spp. Abbreviations: Comp production rate can go up to
five times the basal rate to compensate for RBC loss, Basal
erythrocyte production rate held at basal rate, MDys moderate
dyserythropoiesis: production rate declines by 4.5× rate of loss of
cells due to infection, SDys severe dyserythropoiesis: production rate
declines up to 8.5× rate of cell loss due to infection. Host was
assumed to die if the RBC count dropped to under 60% of the basal
count
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wonders if the dyserythropoiesis observed in some patients
has been shaped by an evolutionary struggle between
humans and Plasmodium spp.
Since even models with plausible immune responses
predict that P. vivax can cause infections as severe as those
of P. falciparum, why does the latter species cause more
severe disease on average than the former, especially in
people who have no previous exposure to either pathogen?
One possible answer is that actual human immune
responses to P. vivax are in a part of the immune system
phase space in which infections are controlled more readily,
either by being detected at a lower threshold than P.
falciparum or by more efficient processes of removal of P.
vivax-infected cells. Furthermore, immune responses are
immensely complex, and perhaps some important compo-
nent has been left out. For example, we did not consider the
effects of antigenic variation in P. falciparum infection, in
which the parasite modifies over time some of its proteins
exposed to the immune system (Hommel et al. 1983). And
RBCs infected with P. falciparum can sequester from the
blood by adhering to vascular endothelium (Udomsangpetch
et al. 2002), which perhaps gives that species an extra ability
to evade immune attack. Although both species produce
factors to suppress host responses (Kubata et al. 1998; del
Portillo et al. 2004), perhaps P. falciparum can achieve
suppression more readily. Yet there is another possibility:
maybe severe P. vivax infection is more common than
thought.
News from the clinic: severe vivax malaria
As we were doing our theoretical work on the population
dynamics of P. vivax, empirical evidence mounted that this
pathogen can cause severe disease after all. In Korea, vivax
malaria was associated with retinal hemorrhaging (Choi et
al. 2004) and splenic infarction (Kim et al. 2007). Kochar et
al. (2005) reported 11 patients with severe malaria (renal
and cerebral complications, severe anemia, fatal outcomes)
from northwestern India in which polymerase chain
reaction (PCR) analysis of parasite DNA as well as
pathology examination showed P. vivax present, but not P.
falciparum [see also Kochar et al. (2007)]. A follow-up
report from that region (Kochar et al. 2009) showed that out
of ≈1,100 patients admitted to a hospital in Bikaner for
malaria, 40 of them had severe malaria in which PCR
analysis could only find P. vivax and not P. falciparum. If
further investigation can confirm this work, then P. vivax is
a more severe public health problem than realized. The
question is not academic, as the drug regime for P. vivax
disease is somewhat different from that for P. falciparum
disease. There are other questions, too, that need investi-
gating: (1) Has severe vivax malaria always been present
but cryptic, or are the cases seen in India and Korea due to
the emergence of new strains? (2) Do patients with severe
vivax malaria have some other health problem that
exacerbates the disease? Only further research will show.
Empirical observation is what ultimately defines the
truth of the matter, but the construction of a plausible
mathematical model of malaria infection can help us
understand why P. vivax can cause severe or even lethal
disease. Of course, not all the pathology is due to anemia,
as it is in the models discussed in this review. Some disease
symptoms will be due to self-damage by the host immune
responses, and perhaps by toxins released by the parasite
(Elsheikha and Sheashaa 2007). Nonetheless, the modeling
shows that there is no a priori reason for P. vivax to be
harmless just because it attacks only a small subset of
RBCs, the reticulocytes. The fact that all RBCs must pass
through the reticulocyte stage means that P. vivax has the
capability to do immense harm, especially if it can interfere
with erythropoiesis in the bone marrow. Many of the vivax
malaria patients described by Kochar et al. (2009) had
severe anemia, a result understandable from our models.
Sensitivity to the standard deviation of the life cycle time
of the intraerythrocyte parasite
In addition to elucidating how severe anemia can come
about, mathematical modeling can help frame other ques-
tions concerning basic malaria biology. One interesting
phenomenon in human malaria is the synchronization of
merozoite release from bursting infected RBCs. Various
mechanisms have been proposed for this: (1) different
effects of fever during the earlier and late parts of the
erythrocytic stage (Kwiatkowski 1995), (2) modulation of
the life cycle of the parasite by immune responses (Hoshen
et al. 2000; Rouzine and McKenzie 2003), and (3)
modulation by the melatonin cycle of the host (Hotta et
al. 2000). We found in our simulation that a quickly acting,
quickly decaying innate response would induce synchro-
nized release of merozoites as illustrated in Fig. 6;
otherwise, bursting of individual parasitized cells becomes
out of phase (McQueen and McKenzie 2008). One question
we investigated was the sensitivity of simulation results to
the standard deviation in the time that parasites spend
within RBCs, σIBC. The value of this quantity by itself does
not determine if synchronization occurs, but it does effect
the duration of merozoite release from the synchronized
bursting of schizonts. In particular, we wanted to know if
short duration of release would enhance the parasite levels
by allowing an evasion of immune pressures.
Simulation results indicate that a small value of σIBC
(“tight” synchronization) might not necessarily benefit the
parasite; in fact, as is apparent in Fig. 7, it might actually
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suppress overall parasitemia. Furthermore, the fraction of
the model parameter space in which the host dies of anemia
is smaller as the standard deviation in the within-host
duration decreases, especially for P. vivax infection. From a
purely dynamical point of view, a tight synchronization of
merozoite release might well benefit the host, not the
parasite. However, one effect not included is the possible
release of a factor that might suppress immune responses: a
quick, overwhelming release of such a factor could boost
parasitemia. Another issue is that for the propagation of the
parasite genome, it is the survival of the gametocytes and
their ability to be taken up by mosquitoes that is important,
and we do not know what bearing tight synchronization has
on that process. Both of these issues merit further empirical
and theoretical investigation.
Some further directions
The production of gametocytes is an area of active research,
as much remains to be discovered. For example, are
gametocytes produced at a constant rate throughout
infection or is their production triggered by some stressor
on the within-host parasite population (Carter and Miller
1979)? Indeed, Diebner et al. (2000) used mathematical
modeling results to argue that the rate of gametocyte
production is highly variable during P. falciparum infection
and is modulated by host innate immunity. Furthermore, the
actual transition steps from asexual forms to gametocytes
are still not known, although careful gene expression
analysis is giving us a clearer answer (Eksi et al. 2008).
Can modeling help with the understanding of that process?
The development of gametocytes differs between P. vivax
and P. falciparum (McKenzie et al. 2007); what are the
implications of that for their population dynamics (and
perhaps on their transmissibility to mosquitoes)? Further
modeling could well prove fruitful in understanding the
genesis and development of gametocytes.
Finally, in the discussions above, I used severe anemia as
a proxy for severity of infection in the hypothetical patient.
But one could easily use additional criteria to define an
infection in which the host is at major risk of dying or
suffering long term disability. For example, the level of
cytokines in a model immune response could be used as a
proxy for possible cerebral damage. One could also
consider a build-up of toxins from the parasite as well.
“What-if” questions could be used to elucidate the
consequences of plausible processes that may damage the
host in cases of malaria.
Fig. 7 a Fraction of points in the parameter space of the model with
immune responses in which simulated infection ended with death of
host as a function of the standard deviation σIBC in the erythrocytic
stage of the parasite. The fraction is of 9,520 simulations: 2,380
combinations of immune response parameters, each with the four
types of erythropoietic responses as given in the legend of Fig. 5. b
Number of parasites produced during infection, IBCINT, averaged over
all points in parameter space for those four values of σ. Squares P.
falciparum , circles P. vivax. Host death was assumed if the RBC
count dropped to under 60% of the basal count
Fig. 6 An example of a time series of the density of merozoites, μ,
from a simulated P. vivax infection. These data are from the same
simulation used to illustrate the gray curves in Fig. 1, panels A–D, in
McQueen and McKenzie (2008). Both a quickly acting, quickly
decaying model innate response and a slowly acting, slowing
decaying antibody response are present. Time=0 marks the beginning
of infection
118 Biophys Rev (2010) 2:111–120
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